[Form 4] Wesco International Inc. Insider Trading Activity
John Engel, Chairman, President & CEO of Wesco International Inc. (WCC), reported multiple transactions on 08/26/2025 and 08/27/2025. He exercised 125,001 stock appreciation rights with a conversion/exercise price of $62.80, resulting in 125,001 shares issued. On the same dates he sold a total of 125,001 shares in multiple transactions at weighted average prices ranging from $224.30 to $227.62, with reported weighted prices of $225.01, $225.74, $226.88 and $227.47 for specific sale groups. Following these transactions his beneficial ownership is reported as 475,971.1888 shares.
- Exercise of SARs: 125,001 Stock Appreciation Rights were exercised at a $62.80 exercise price, resulting in issuance of 125,001 shares.
- Timely disclosure: Transactions were reported on a Form 4 with explanatory footnotes and an attorney-in-fact signature.
- Large insider sales: 125,001 shares were sold in multiple transactions at weighted prices ranging up to $227.62, reducing beneficial ownership.
- Potential dilution: The SAR exercise resulted in new shares issued (125,001) which may increase outstanding share count (documented issuance).
Insights
TL;DR: Insider exercised SARs and immediately sold an equal number of shares, leaving reported beneficial ownership at 475,971.1888 shares.
The Form 4 shows an exercise of 125,001 stock appreciation rights at a $62.80 exercise price, producing 125,001 common shares. Subsequent sales on 08/26-08/27/2025 disposed of 125,001 shares across several transactions at weighted average prices within the $224.30–$227.62 ranges, with reported weighted averages for blocks at about $225–$227. The net effect is a reduction from 600,972.1888 shares pre-sales to 475,971.1888 shares post-sales. These are routine insider liquidity actions following SAR vesting and are informational for share supply and insider behavior.
TL;DR: The filing documents standard executive exercises and market sales tied to vested SARs; no governance irregularities disclosed.
The record indicates vested Stock Appreciation Rights became exercisable in installments and 125,001 were exercised on 08/26/2025. The concurrent sales of an equal number of shares were disclosed with weighted average sale prices across multiple execution ranges. The Form 4 is properly signed by an attorney-in-fact and contains explanations for price ranges. There is no information in this filing indicating policy deviations, related-party issues, or unusual delays in disclosure.